Performance of Limited Sampling Strategies for Predicting Mycophenolic Acid Area Under the Curve in Thoracic Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 3, 2008, Pages 325-328

  Ting, Lillian S L ^a   Partovi, Nilufar ^a,b   Levy, Robert D ^a,b,c   Ignaszewski, Andrew P ^a,c,d   Ensom, Mary H H ^a,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c British Columbia Transplant Society   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

^e CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIMITED SAMPLING STRATEGY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; SAMPLING; SURGICAL PATIENT;

AGED; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDICTIVE VALUE OF TESTS; SAMPLING STUDIES;

EID: 40749120350     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.12.009     Document Type: Article

References (16)

1. van Gelder T., Le Meur Y., Shaw L.M., et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit 28 (2006) 145-154
2. van Gelder T., and Shaw L.M. The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation. Transplantation 80 suppl (2005) S244-S253
3. Shaw L.M., Holt D.W., Oellerich M., Meiser B., and van Gelder T. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit 23 (2001) 305-315
4. Shaw L.M., Nicholls A., Hale M., et al. Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem 31 (1998) 317-322
5. de Winter B.C., Mathot R.A., van Hest R.M., and van Geler T. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?. Expert Opin Drug Metab Toxicol 3 (2007) 251-261
6. Ting L.S., Villeneuve E., and Ensom M.H. Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants. Ther Drug Monit 28 (2006) 419-430
7. Baraldo M., Isola M., Feruglio M.T., et al. Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients. Transplant Proc 37 (2005) 2240-2243
8. Wada K., Takada M., Kotake T., et al. Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment. Circ J 71 (2007) 1022-1028
9. Ting L.S., Partovi N., Levy R.D., Riggs K.W., and Ensom M.H. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients. Pharmacotherapy 26 (2006) 1232-1240
10. Ting L.S., Partovi N., Levy R.D., Riggs K.W., and Ensom M.H. Pharmacokinetics of mycophenolic acid and its glucuronidated metabolites in stable lung transplant recipients. Ann Pharmacother 40 (2006) 1509-1516
11. Sheiner L.B., and Beal S.L. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 9 (1981) 503-512
12. Hesselink D.A., van Hest R.M., Mathot R.A., et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 5 (2005) 987-994
13. Zucker K., Tsaroucha A., Olson L., et al. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther Drug Monit 21 (1999) 35-43
14. Staatz C.E., and Tett S.E. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46 (2007) 13-58
15. Roche Laboratory, Inc. CellCept (mycophenolate mofetil) drug monograph (2003) March
16. Billingham R.E., Nicholls A.J., and Kamm B.R. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34 (1998) 429-455